Full text

Turn on search term navigation

© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Eucommiae Cortex (EC) is frequently used alone or in combination with other active ingredients to treat a range of illnesses. An efficient technical instrument for changing cheap or plentiful organic chemicals into rare or costly counterparts is biotransformation. It combines EC with biotransformation techniques with the aim of producing some novel active ingredients, using different strains of bacteria that were introduced to biotransform EC in an aseptic environment. The high-quality strains were screened for identification after the fermentation broth was found using HPLC, and the primary unidentified chemicals were separated and purified in order to be structurally identified. Strain 1 was identified as Aspergillus niger and strain 2 as Actinomucor elegans; the main transformation product A was identified as dehydrodiconiferyl alcohol (DA) and B as pinoresinol (Pin). The biotransformation of EC utilizing Aspergillus niger and Actinomucor elegans is reported for the first time in this study’s conclusion, resulting in the production of Pin and DA.

Details

Title
Preparation of Pinoresinol and Dehydrodiconiferyl Alcohol from Eucommiae Cortex Extract by Fermentation with Traditional Mucor
Author
Jiang, Wenyi 1 ; He, Zhengyou 2 ; Yao, Ruijiao 1 ; Chen, Zhiyang 3 ; Zeng, Xia 3 ; Zheng, Miao 3 ; Wang, Jing 3 ; Li, Jia 3 ; Jiang, Yong 3 

 School of Food and Biological Engineering, Chengdu University, Chengdu 610106, China; [email protected] (W.J.); [email protected] (R.Y.) 
 School of Food and Biological Engineering, Chengdu University, Chengdu 610106, China; [email protected] (W.J.); [email protected] (R.Y.); School of Pharmacy, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu 610106, China; [email protected] (Z.C.); [email protected] (X.Z.); [email protected] (M.Z.); [email protected] (J.W.); [email protected] (J.L.); [email protected] (Y.J.) 
 School of Pharmacy, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu 610106, China; [email protected] (Z.C.); [email protected] (X.Z.); [email protected] (M.Z.); [email protected] (J.W.); [email protected] (J.L.); [email protected] (Y.J.) 
First page
2979
Publication year
2024
Publication date
2024
Publisher
MDPI AG
e-ISSN
14203049
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3079208266
Copyright
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.